Federal Circuit reverses district court’s on-sale bar ruling

02-05-2017

Federal Circuit reverses district court’s on-sale bar ruling

Mari / iStockphoto.com

The US Court of Appeals for the Federal Circuit ruled yesterday that a patent is invalid if the invention was sold before being patented, even if the invention was not publicly disclosed.


Federal Circuit, AIA, Helsinn Healthcare, Teva, patent, ANDA, FDA, on-sale bar

LSIPR